Literature DB >> 22909826

Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study.

Yesim Dargaud1, Alisa S Wolberg, Roger Luddington, Veronique Regnault, Henri Spronk, Trevor Baglin, Thomas Lecompte, Hugo Ten Cate, Claude Negrier.   

Abstract

The thrombin generation test (TGT) has demonstrated utility in evaluating overall hemostatic capacity both in bleeding and thrombotic disorders. Although the test is currently well accepted as a research tool, its role in clinical practice has not yet been defined through large prospective multicenter clinical studies. Such prospective studies have been limited by the lack of official standardization of the assay and its large inter-laboratory variability. This international study assessed the intra- and inter-assay imprecision of TGT as well as the inter-centre variability of results in one US and four European centres. Contact-inhibited plasmas from six healthy volunteers, one mild haemophilia A patient, and five patients with heterozygous prothrombin G20210 mutation were assayed. We demonstrated that, using identical equipement, standardized reagents, a carefully selected reference plasma for normalization of results and the same test procedure as described in our DVD, the assay variability was highly reduced compared to previously published data. Our results emphasize the importance of preheating on TGT results and the variability of the assay. In conclusion, our data demonstrated that the standardized TGT methodology evaluated in this study effectively reduces the variability of the assay to acceptable limits and may be used in clinical trials.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909826     DOI: 10.1016/j.thromres.2012.07.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  37 in total

Review 1.  Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future.

Authors:  Victor Jiménez-Yuste; Günter Auerswald; Gary Benson; Thierry Lambert; Massimo Morfini; Eduardo Remor; Silva Zupančić Salek
Journal:  Blood Transfus       Date:  2014-07       Impact factor: 3.443

Review 2.  Global coagulation assays: a clinical perspective.

Authors:  Ayesha Zia; Sarah H O'Brien
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

3.  Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Authors:  Bryce A Kerlin; Amanda P Waller; Ruchika Sharma; Melinda A Chanley; Marvin T Nieman; William E Smoyer
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

4.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Authors:  Y Dargaud; A S Wolberg; E Gray; C Negrier; H C Hemker
Journal:  J Thromb Haemost       Date:  2017-06-28       Impact factor: 5.824

5.  Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.

Authors:  Myung S Park; Ailing Xue; Grant M Spears; Timothy M Halling; Michael J Ferrara; Melissa M Kuntz; Sabtir K Dhillon; Donald H Jenkins; William S Harmsen; Karla V Ballman; Paul Harrison; John A Heit
Journal:  J Trauma Acute Care Surg       Date:  2015-11       Impact factor: 3.313

Review 6.  Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.

Authors:  Guy Young; Benny Sørensen; Yesim Dargaud; Claude Negrier; Kathleen Brummel-Ziedins; Nigel S Key
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

7.  Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Authors:  Gillian N Gidley; Lori A Holle; John Burthem; Paula H B Bolton-Maggs; Feng-Chang Lin; Alisa S Wolberg
Journal:  Blood Adv       Date:  2018-05-22

Review 8.  Global assays of hemostasis.

Authors:  Kathleen E Brummel-Ziedins; Alisa S Wolberg
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

9.  A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop).

Authors:  Jonathan Langdown; Roger J Luddington; James A Huntington; Trevor P Baglin
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

10.  Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.

Authors:  Kate Burley; Claire S Whyte; Sarah K Westbury; Mary Walker; Kathleen E Stirrups; Ernest Turro; Oliver G Chapman; Christopher Reilly-Stitt; Nicola J Mutch; Andrew D Mumford
Journal:  Blood       Date:  2016-07-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.